Market regulator Securities and Exchange Board of India (SEBI) on Thursday morning announced its decision to impose a penalty on pharmaceutical major Divi’s Laboratories’ Chief Financial Officer L Kishore Babu, along with seven other persons for violating the insider trading rules.
